Connect with us

Business

Billroth Hospitals launches Liver Transplant Centre at Chennai

blank

Published

on

blank

Chennai (Tamil Nadu) [India], September 27 (ANI/NewsVoir): Billroth Super Speciality Hospitals, one of the leading hospitals in Chennai, has successfully performed a liver transplant surgery for a 62-year-old man.

With this, the hospital also marks the launch of Liver Transplant Centre. The inauguration was done recently, by Thiru. Ma. Subramanian, Hon’ble Minister of Health and Family Welfare, Tamil Nadu. Also present on the occasion Thiru M.K Mohan MLA, Anna Nagar Constituency, Chennai.

The patient, from Bengaluru, was affected by Cirrhosis due to infection of Hepatitis B. He was diagnosed for Hepato Cellular carcinoma (primary liver cancer). Speaking further on the case, Dr. Elankumaran, Liver Transplant Surgeon, says, “The patient was examined for the intensity of Cirrhosis and we found him to be fit for a liver transplant. A brain dead patient’s family was willing for organ donation hence this patient was taken for deceased donor liver transplantation. The patient was then shifted to the ICU for post-operative care where he was given immunosuppressive medications and monitored for any infections. His liver functions were normal after the transplant and he was discharged on the fifth day.”

Liver Transplantation is the best option for a patient who is diagnosed with end-stage liver cirrhosis or cancer. The transplantation not only cures the cancer but also prevents the recurrence of cancer. The need for Liver Transplants numbers around 25,000 cases per year in India (both living and cadaver), however the current capacity is about 2,000 Liver Transplants per year. Timely diagnosis and intervention can prevent death.

The Liver Diseases and Transplant centre will be headed by Dr. Elankumaran, who has performed over 1,700 transplants in his career. The team will also consist of highly qualified surgeons such as Dr. Sugi Subramaniam, Dr. Sivaraj & Dr. Sankar Narayanan, Anaesthetists – Dr. Kulaseharan, Dr. Hari Balakrishnan, Dr. Rengarajan and Dr. Suresh. Expert post-operative care with well-equipped infrastructure ensures faster and safer recovery. An expert and well trained team of nurses, post-operative care specialists and paramedics aid in the recovery process of Liver Transplant patients to ensure optimal outcomes.

Billroth Hospitals which was launched in 1990, with a 30 bedded facility is now a multi-speciality 350 bedded facility placed at two prime locations in the city. Billroth Institute of Gastroenterology (BIG) is one of the oldest and finest departments in South India. The team with highly skilled professionals in Luminal Gastroenterology, Hepatology & Nutrition under one roof, handles close to 100 walk-ins, 25 procedures & surgeries in a day and takes the credit for having managed over 5 lakh patients so far. It was established by Dr. V. Jeganathan, a legendary Gastroenterologist for almost 3 decades. Today, it has emerged as one of the best hospitals for Gastroenterology & Hepatology in Chennai city. Its Liver Clinic offers comprehensive treatment for all kinds of liver diseases starting from medical management of liver diseases to transplants.

“We are proud to say Billroth Super Speciality Hospitals in Chennai city has the most experienced and well-trained doctors at Billroth Institute of Gastroenterology (BIG). The COVID-19 pandemic caused an acute shortage of cadaver organs. As a result, a large number of patients were waitlisted for elective surgeries and transplants were stopped in many hospitals from March last year when the pandemic struck. Patients waiting for organ transplants in Chennai hospitals had to wait longer as transplants could not be resumed amid the high-viral atmosphere due to COVID-19.

Factors like determining the COVID status of donors, the risk of recipients getting infected during or after the transplant and ensuring a safe atmosphere for the surgery, also played a crucial role. Organ transplants have been affected due to the pandemic. The demand has gone up and donors have become harder to come across. It is estimated that on an average, about 400 people wait for cadaver livers in a year in the state. Hundreds of patients wait for donors and finally lose their lives due to inability to procure the organ. The condition of other patients waiting for kidneys, heart and lung is also precarious,” says Dr. Rajesh Jeganathan, Chairman and Managing Director, Billroth Hospitals.

Even though there was an acute shortage of organs, during the COVID-19 surge Billroth Hospitals has been offering undeterred treatment to patients with strict infection control measures. “People from all walks of life with Gastrointestinal and Liver issues can walk into Billroth Institute of Gastroenterology and avail the best treatments at affordable cost.

The hospital is equipped with all the latest diagnostics & techniques prevalent in the industry and is strongly backed by an existing expert panel of doctors to handle critical cases,” he adds.

The facilities available at the newly launched “Liver Transplant Unit” at Billroth Hospitals include:

Liver transplant

Round the clock trained Hepatologist

Comprehensive 24/7 management of liver diseases and complications

State of art liver ICU

Liver Dialysis

Advanced liver cancer treatment

Trans-Arterial Chemo Embolisation

Radio-frequency Ablation

Trans-Arterial Radio Embolisation

Speaking about the launch of the Liver Transplant Centre, Dr. Shrilekha Venkatesan, Medical Superintendent, Billroth Hospitals says, “The Transplant centre will be an addition to the pre-existing ‘BIG’ (Billroth Institute of Gastroenterology), with advanced infrastructure and equipment. Being a pioneer in the healthcare industry, we believe the hospital would continue to render more quality healthcare services with the right infrastructure and expertise.”

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

DISCLAIMER

(This story has not been edited by PRESS24 NEWS staff and is auto-generated from a syndicated feed.)

 

Dear Reader,

PRESS24 NEWS has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to PRESS24 NEWS.

Digital Editor


Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.

Source link

Business

Dip in Covid-specific policy sales as consumers go for comprehensive covers

blank

Published

on

blank


Demand for short-term Covid-specific policies has dipped considerably with consumers understanding the need to get comprehensive coverage against all health-related risks and insurers reluctance to aggressively push for such products, given the huge claims they have seen from this segment and the low premiums that these products fetch.


However, despite losing money on short-term Covid specific products, insurers say they will offer them to customers till the time the regulator has specified.





Recently, the insurance regulator issued circular asking insurers to offer and renew short-term Covid specific products, including Corona Kavach and Corona Rakshak till March 31, 2022. It had extended the timeline for the sale and renewal of such policies till September this year, given the second wave.


The industry has not particularly been upbeat about selling these products, though they were highly in demand during the first wave of Covid. Till this March, the standard Covid-specific indemnity-based policy Corona Kavach covered 4.2 million lives, while the standard benefit-based product Corona Rakshak covered 540,000 lives. And, all Covid specific policies together have covered more than 13.5 million lives.


In the past, the regulator has pulled up the insurers for being reluctant to offer these products to consumers and mandated them to offer Corona Kavach, an indemnity-based standard Covid-specific product introduced by the regulator last year.


Industry insiders are of the view that when these products were introduced last year, insurers sold them to help people get coverage against Covid. These are short-term products hence people priced them accordingly but now insurers may have to revisit their stance on pricing. The loss ratio has been adverse on these products. Also, some insurers are of the opinion that these products are undercutting their comprehensive products.


Experts said the decision to push these Covid specific products now will be a function of how insurers perceive the risk associated with such products and how the consumers view Covid risk in the coming months.


“We are still offering these products but what we have noticed is the demand for such products have come down.”, said the CEO of a private sector insurer.


An industry veteran, on the condition of anonymity, said insurers have suffered huge losses in the segment as the premium for these products is very low but the claims they have received have been particularly high. So, it will depend on each company if they want to push such products aggressively. Even the companies who decide to push these products may ask for a price correction.


“These products have seen a lot of claims but if there is no third wave, then it should not be a huge problem for insurers. But, these products should not be stretched beyond a point and the focus should be on creating awareness for comprehensive products and incentivise them by perhaps reducing the GST rate on health premiums”, the private sector CEO quoted above said.


The Covid specific products were designed to address the needs of the consumers when Covid hit because at that time there was a lot of confusion if normal health products covered Covid and the consumables. And, these standard Covid specific plans were influential in creating awareness and educating the masses about health insurance.


“..they were quite instrumental in giving a cushion to the uninsured people. However, with the vaccination drive being in full swing, the controlled number of Covid19 cases, and an understanding of the fact that comprehensive health plans offer the complete treatment for the Covid19 and its after-effects, there is a diminishing pattern in the demand for Covid specific plans”, said Naval Goel, Founder & CEO, PolicyX.com


“The current demand for this kind of policies has been muted since many of the users are now aware that Covid 19 is also covered in the base plan, and the demand of the policy might be seen rising when the third wave hits, the reason for low demand of these policies have been mass vaccination and rise in awareness among users”, said John Mayne, Executive Director, Coverfox.

Dear Reader,

PRESS24 NEWS has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to PRESS24 NEWS.

Digital Editor


Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.

Source link

Continue Reading

Business

Apple’s new iPhone to take longer to reach customers, say analysts

blank

Published

on

blank


Apple Inc’s customers will have to wait for a few more weeks to lay their hands on the new iPhone 13 as supply chain delays and strong demand lead to one of the longest waiting times for the phone in recent years, analysts said.


The delivery time for Apple’s iPhones after a new launch is watched by analysts as one of the measures to gauge demand for the flagship phone’s newest model. But this year, it is also shining a light on supply chain issues plaguing technology companies ahead of the holiday shopping season.





Analysts at J.P.Morgan and Credit Suisse said customers across the world who had pre-ordered the new models online would have to wait more than four weeks for the iPhone 13 Pro and Pro Max and about 2 weeks for the base iPhone 13.


In the United States, which accounts for over a third of iPhone shipments, the delivery time for the iPhone 13 series was 19 to 34 days in the second week, compared with 7 to 20 days in the first week, both greater than the lead times for the iPhone 12 Series.


Apple was not immediately available to comment on the delays in delivery times.


“While admittedly part of the expansion in the lead times is on account of the supply chain constraints, we still find the material increase in the lead time in Week 2 relative to Week 1 as an indicator of the robust demand for upgrades, likely exceeding low investor expectations into the launch,” J.P.Morgan analyst Samik Chatterjee said.


Apple’s partners Verizon, Vodafone UK and Best Buy cited high demand and product supply issues in replies to customers on Twitter. Many users on social media also flagged the delays.


“With a delay on the delivery for iPhone 13 pro max I might as well cancel! They talking (about until) October 30th,” one user said on Twitter.


On Sunday, several Apple and Tesla Inc suppliers suspended production at some Chinese factories for a number of days to comply with tighter energy consumption policies, putting supply chains at risk in the peak season for electronics goods.


The iPhone 13, priced between $699 and $1,599, comes with a sharper camera, a new bionic chip and improved connectivity. It has been available for pre-booking since Sept. 17.


 

(Only the headline and picture of this report may have been reworked by the PRESS24 NEWS staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

PRESS24 NEWS has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to PRESS24 NEWS.

Digital Editor




Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.

Source link

Continue Reading

Business

Business News | Stock and Share Market News

blank

Published

on

blank

















Moneycontrol


Moneycontrol PRO


Moneycontrol PRO















Kumar has launched his new venture called Warpli, a full fledged online marketplace which will compete with incumbents such as Amazon and Flipkart in the hyper competitive market..

Exclusive: Grofer's Saurabh Kumar launches e-commerce firm Warpli; to compete with Amazon, Flipkart


  • हफ्ते के पहले दिन बाजार फ्लैट बंद, जानिए कल कैसी रह सकती है इसकी चाल
  • अहम खबरें: फोकस में में Zee Ent और पेपर कंपनियां, लैंड मोनेटाइजेशन पर NLMC का गठन जल्द
  • Icra ने देश के GDP growth अनुमान को बढ़ाकर किया 9%, बताई ये वजह
  • Reliance Industries के शेयर रिकॉर्ड हाई पर, जानें क्या अभी कर सकते हैं नया निवेश?
  • Labour Codes: 1 अक्टूबर से करनी होगी 12 घंटे की नौकरी, क्या मोदी सरकार लागू करेगी नये नियम?
  • Persistent Systems के फाउंडर ने कहा, बिलियनेयर बनने से कुछ खास नहीं बदला
  • महाराष्ट्र राज्यसभा उपचुनाव: BJP कैंडिडेट ने वापस लिया नाम, कांग्रेस का निर्विरोध जीतना तय
  • Reliance Retail की नायका के IPO के पहले आनलाइन कॉस्मेटिक कारोबार में उतरने की तैयारी-मीडिया रिपोर्ट
  • Bhabanipur By Election: भवानीपु में BJP नेताओं से हाथापाई के बाद चुनाव आयोग ने ममता सरकार से मांगी रिपोर्ट
  • बिना इंटरनेट के भी Google Pay, Paytm से कर सकते हैं पेमेंट, जानें स्टेप बाय स्टेप तरीका
  • इस एप के जरिए PAN, आधार और EPFO से जुड़े का काम करें घर बैठे, जानें डिटेल्स
  • टोयोटा की सेडान Yaris की देश में बंद होगी बिक्री, नए मॉडल्स लॉन्च करेगी कंपनी
  • Sensex-Nifty को लगे पंख, इस तेजी में अगले 3-4 हफ्ते में ये शेयर कराएंगे जोरदार कमाई
  • उतार-चढ़ाव के बीच Sensex-Nifty फ्लैट हुए बंद, Auto शेयरों में रही बढ़त, IT फिसले
  • मार्केट के हाई लेवल्स पर होने के साथ India VIX 5 प्रतिशत बढ़ा, प्रॉफिट बुकिंग का इशारा



Name Price Change % Chg
Indiabulls Hsg 233.00 7.15 3.17
Sbi 446.60 5.85 1.33
Ntpc 126.85 2.60 2.09
Rec 151.60 -1.00 -0.66

Forum

Forum

YOUR OPINION

Which of these youngsters will score more runs this ipl?

Which of these youngsters will score more runs this ipl?

COMMENTS

Thank You for Voting